Scarica l'app Stockscreener
36.80
2.05%
-0.77
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HIMS Giù?
Forum
Previsione
Hims Hers Health Inc Borsa (HIMS) Ultime notizie
HIMS Stock Jumps 8% as JPMorgan Facility and Analyst Upgrades Fuel Rally - FXLeaders
HIMS Stock Hits 2026 High After Unlocking $400M Working Capital Through JPMorgan — Retail Gets Less Bearish - Stocktwits
Hims & Hers Health Enters Receivables Purchase Agreement with JPMorgan Chase Bank – Key Terms and Details - Minichart
Hims & Hers Establishes New $400 Million Receivables Facility - TipRanks
Hims & Hers Launches $400 Million Receivables Facility, Amends Revolver to Support Program - TradingView
Hims & Hers (HIMS) adds $400M receivables facility and amends credit deal - Stock Titan
HIMS Stock Surges as Canaccord Genuity Raises Price Target - GuruFocus
Hims & Hers Stock Surges as Analysts Lift Price TargetsHims & Hers Health (NYSE:HIMS) - Benzinga
Hims & Hers stock jumps as Canaccord lifts target ahead of FDA review - TradingView
Hims & Hers Health (NYSE:HIMS) run trims Canaccord upside after GLP-1 reset - TechStock²
BofA raises Hims and Hers stock price target on FDA peptide review - Investing.com
Hims stock gains as FDA revives AdComs (HIMS:NYSE) - Seeking Alpha
HIMS Maintains by B of A Securities -- Price Target Raised to $3 - GuruFocus
HIMS Maintained by Canaccord Genuity -- Price Target Raised to $40 - GuruFocus
Why is Hims & Hers Health stock rallying today? By Investing.com - Investing.com Canada
Hims & Hers stock rises after Canaccord price target hike - Investing.com
Hims & Hers Health, Inc. Stock 12‑Month Price Target Raised to $29.27, Implies 16% Downside - TradingView
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Canaccord raises Hims and Hers stock price target on weight loss drugs - Investing.com Canada
HIMS Stock Slips Overnight After FDA Staff Questions Safety Of Popular Peptides — But One Analyst Says ‘This Isn’t The End’ - Stocktwits
Hims & Hers Health Inc (HIMS) Shares Surge 3.8% -- What GF Score of 81 Tells Investors - GuruFocus
Hims & Hers Health, Inc. (HIMS) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
HIMS Stock On The Mend? New Testosterone Push Builds As GLP-1 Gold Rush Gets Crowded - Stocktwits
Lost Money on Hims & Hers Health, Inc. (HIMS)? Join Class Action Before August 25, 2025Contact Levi & Korsinsky - The National Law Review
Join Class Action to Recover Losses from Hims & Hers Health, Inc - The National Law Review
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Hims & Hers - The National Law Review
Hims & Hers Health Stock (HIMS) Opinions on Business Reacceleration and Analyst Upgrades - Quiver Quantitative
Class Action Filed Against Hims & Hers Health, Inc. (HIMS) Over Securities ViolationsContact Levi & Korsinsky Today - The National Law Review
Trading the Move, Not the Narrative: (HIMS) Edition - Stock Traders Daily
HIMS Stock Eyes Big Monthly Win: Novo Nordisk Calls Hims & Hers One Of Its Most ‘Voluminous’ Telehealth Partners - Stocktwits
OMCL or HIMS: Which Is the Better Value Stock Right Now? - Yahoo! Finance Canada
Hims & Hers Soars After Novo Nordisk Weight-Loss Nod - TipRanks
Hims & Hers: Can Fundamentals Really Support This Rebound Rally? (Downgrade) (NYSE:HIMS) - Seeking Alpha
Why is Hims & Hers Health stock up today? - Traders Union
Key facts: Hims sells GLP‑1s; 2.6M subs; Barclays $39, Leerink $25 - TradingView
Investor relations - HIMS Investor Relations
HIMS Stock | Hims & Hers Health, Inc. Price, Quote, News & Analysis - TipRanks
HIMS News | HIMS & HERS HEALTH INC (NYSE:HIMS) - ChartMill
Hims & Hers Health slips as investors continue to weigh margin pressure and recent financing - Quiver Quantitative
Hims’ obesity drug business may get boost as employers drop coverage - WTVB
Analysis-Hims’ obesity drug business may get boost as employers drop coverage - WHTC
$Hims & Hers Health (HIMS.US)$ - Moomoo
Barclays Raises Price Target On Hims & Hers Health (NYSE: HIMS) As Weight Loss Business Drives Momentum - foreignpolicyjournal.com
Hims & Hers Health Options Spot-On: On June 24th, 62,597 Contracts Were Traded, With 937.02K Open Interest - Moomoo
CVS expands direct-to-consumer GLP-1 weight-loss program - The Business Journals
Is Hims & Hers Health, Inc. (HIMS) a Top Weight Loss Stock After Barclays’ Target Increase? - Insider Monkey
Form 4 Hims Hers Health Inc For: 23 June By Investing.com - Investing.com Nigeria
Hims & Hers CMO Patrick Carroll sells $830,410 in stock By Investing.com - Investing.com Canada
Hims & Hers CFO Oluyemi Okupe sells $619,216 in shares By Investing.com - Investing.com Canada
Hims & Hers (NYSE: HIMS) CMO sells 23,726 shares, retains 181,861 - Stock Titan
[Form 4] Hims & Hers Health, Inc. Insider Trading Activity - Stock Titan
Hims & Hers Health, Inc. (HIMS) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance
Hims & Hers Health (HIMS) Expands GLP 1 Offerings With Novo Nordisk Deal And Eucalyptus Buy - Yahoo Finance
2 Unpopular Stocks That Deserve a Second Chance and 1 We Question - The Globe and Mail
A Look at Hims & Hers Health Inc (HIMS) After 5.4% Decline -- GF Value $38.53 vs Price $33.54 - GuruFocus
HIMS Stock Logs Best Day In 2 Months: Bull Sees Peptides Driving Up To $19B In Annual Revenue By 2030 - Stocktwits
CVS Health Corp Stock (CVS) Moved Up by 4.56% on Jun 22: Key Drivers Unveiled - TradingKey
Telehealth platform names Dr. Anant Vinjamoori as Hims CMO - The American Bazaar
Hims & Hers Health stock price forecast: $39.50 resistance in focus as HIMS surges on Eucalyptus deal - Traders Union
HIMS Stock Slides Overnight: Insider Files Share Sale As CEO Teases Oura Wearable Integration - Stocktwits
HIMS Stock Gained Nearly 6% On Wednesday — Barclays Sees Breakout Potential After Novo Partnership - Stocktwits
5.53%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):